BST/BSFA (BST/BSFA)

Stuttgart Stock Exchange: BST/BSFA · EUR

€63.5

-1.00 (-1.6%)· Recorded snapshot

Market cap	1.4B
Revenue (ttm)	856.4M
Net income (ttm)	87.2M
EPS (ttm)	€4.08
P/E (trailing)	15.6x
P/E (forward)	7.6x

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 856.4M
Net income (ttm): 87.2M
EPS (ttm): €4.08
P/E (trailing): 15.6x
P/E (forward): 7.6x
Market cap: 1.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E7.6

P25 n/aP50 n/aP75 n/a

Trailing P/E15.6

P25 n/aP50 n/aP75 n/a

ROE20.5

P25 n/aP50 n/aP75 n/a

ROIC11

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BST/BSFA indicators

Market & fundamental data

Available fields

231

Groups with data

Currency

USD

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	DE
Earnings date	2026-11-05
Employees	970
Employees change	255
Employees growth	39.72%
Enterprise value	EUR 1.6B
Exchange	Stuttgart Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2001
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	US00182C1036
Last earnings date	2026-08-07
Last refreshed	2026-10-28
Market cap	EUR 1.4B
Next earnings date	2026-11-05
Price	EUR 63.50
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	bst/BSFA
Website	https://www.anipharmaceuticals.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	48.42x
Earnings yield	6.42%
EV/Earnings	18.27x
EV/EBIT	14.35x
EV/EBITDA	8.31x
EV/FCF	10.52x
EV/Sales	1.81x
FCF / EV yield	9.51%
FCF yield	11.06%
Forward P/E	7.56x
Graham number	46.97492
Graham upside	-26.02%
Industry forward P/E	17.53x
Industry P/E	28.54x
P/(FCF - SBC) ratio	11.85x
P/(OCF - SBC) ratio	10.54x
P/B ratio	2.62x
P/E ratio	15.58x
P/FCF ratio	9.04x
P/OCF ratio	8.25x
P/S ratio	1.6x
Price / tangible book value	18.42x
Price/EBITDA ratio	7.47x
Sector forward P/E	14.95x
Sector P/E	40.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	12.63%
EBITDA margin	21.4%
Effective tax rate	24.04%
FCF margin	17.24%
Gross margin	60.4%
Operating margin	12.63%
Pretax margin	14.57%
Profit margin	11.07%
Profit per employee	EUR 89,873
Profitable quarters	6
Profitable years	1
Revenue per employee	EUR 882,861
ROA	5.45%
ROA (5Y)	0.9%
ROCE	10.21%
ROE	20.46%
ROE (5Y)	-2.48%
ROIC	10.96%
ROIC (5Y)	2.07%
SBC / revenue	4.2%
Tax / revenue	3.5%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (Q)	191.07%
EPS growth (QoQ)	-17.54%
EPS growth 10Y	18.22%
EPS growth quarters	5
EPS growth years	1
FCF growth	37.9%
FCF growth (Q)	-25.33%
FCF growth (QoQ)	2.51%
FCF growth 3Y	77.72%
FCF growth 5Y	84.53%
Gross profit growth	26.61%
Gross profit growth (Q)	21.3%
Gross profit growth 3Y	32.74%
Gross profit growth 5Y	37.03%
Net income growth (Q)	189.05%
Net income growth (QoQ)	-16.15%
Net income growth quarters	5
Net income growth years	1
OCF growth	36.17%
OCF growth (Q)	-25.25%
OCF growth (QoQ)	-2.92%
OCF growth 10Y	20.55%
OCF growth 3Y	66.2%
OCF growth 5Y	69.39%
Operating income growth	243.51%
Operating income growth (Q)	162.63%
Operating income growth 3Y	46.44%
Revenue growth	30.91%
Revenue growth (Q)	25.87%
Revenue growth (QoQ)	12.04%
Revenue growth 10Y	26.96%
Revenue growth 3Y	34.58%
Revenue growth 5Y	35.6%
Revenue growth quarters	19
Revenue growth years	14

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -14.4M
Depreciation and amortization	EUR 77M
EBIT	EUR 108.2M
EBITDA	EUR 183.3M
EPS	EUR 4.08
Financing cash flow	EUR -21.5M
Free cash flow	EUR 151.4M
Free cash flow minus SBC	EUR 115.5M
Gross profit	EUR 517.3M
Income taxes	EUR 30M
Investing cash flow	EUR -19.2M
Net borrowing	EUR -12.8M
Net cash flow	EUR 124.7M
Net income	EUR 87.2M
Operating cash flow minus SBC	EUR 129.9M
Operating income	EUR 108.2M
Revenue	EUR 856.4M
Stock-based compensation	EUR 35.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.53
Book value per share	EUR 24.39
Debt / EBITDA	2.93
Debt / equity	1.05
Debt / FCF	3.62
Goodwill	EUR 56.1M
Interest coverage	4
Long-term assets	EUR 566.7M
Long-term liabilities	EUR 530.4M
Net cash (debt)	EUR -218M
Net cash / market cap	-15.93%
Net debt / EBITDA	1.19
Net debt / equity	0.42
Net debt / FCF	1.44
Piotroski F-Score	7
Property, plant and equipment	EUR 65.7M
Shareholders' equity	EUR 522.7M
Tangible book value	EUR 74.3M
Tangible book value per share	EUR 3.47
Total assets	EUR 1.3B
Total cash	EUR 330M
Total debt	EUR 548M
Total liabilities	EUR 785.1M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.69
Current assets	EUR 741.1M
Current liabilities	EUR 254.7M
Current ratio	2.91
Inventory turnover	2.75
Net working capital	EUR 162.9M
Quick ratio	2.3
Working capital	EUR 474.2M
Working capital turnover	1.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-12.56%
Payout ratio	0.32%
Shareholder yield	-12.56%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	4.99%
10Y return CAGR	0.49%
10Y total return	4.99%
150-day SMA	EUR 67.23
1D price change	-1.55%
1M price change	-2.31%
1M total return	-2.31%
1W price change	-1.55%
1W total return	-1.55%
1Y price change	-21.12%
1Y return CAGR	-21.13%
1Y total return	-21.12%
20-day SMA	EUR 64.28
200-day SMA	EUR 66.95
3M price change	-7.3%
3M total return	-7.3%
3Y price change	13.39%
3Y return CAGR	4.28%
3Y total return	13.39%
50-day SMA	EUR 63.75
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 84.00
52-week high date	2025-10-27
52-week low	EUR 59.50
52-week low date	2026-09-09
5Y price change	95.99%
5Y return CAGR	14.41%
5Y total return	95.99%
6M price change	-4.51%
6M total return	-4.51%
All-time high	EUR 84.00
All-time high date	2025-10-27
All-time low	EUR 4.36
All-time low date	2013-08-09
Average true range (ATR)	EUR 1.61
Average volume	6.5
Change from 52-week high	-24.4%
Change from 52-week low	6.72%
Change from all-time high	-24.4%
Change from all-time low	1,355.75%
Change from open	-2.31%
Day's gap	0.78%
High price	EUR 65.00
Low price	EUR 63.50
Monthly RSI	50.81
Open price	EUR 65.00
Position in 52-week range	0%
Previous close	EUR 64.50
Price vs 150-day SMA	-5.54%
Price vs 20-day SMA	-1.21%
Price vs 200-day SMA	-5.15%
Price vs 50-day SMA	-0.39%
Relative volume	3.08
RSI	46.11
Sharpe ratio	-0.57
Sharpe ratio (3Y)	0.17
Sharpe ratio (5Y)	0.36
Sortino ratio	-0.65
Sortino ratio (3Y)	0.42
Sortino ratio (5Y)	0.66
Weekly RSI	45.24
YTD price change	-6.62%
YTD total return	-6.62%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19.7M
Shares change (QoQ)	1.72%
Shares change (YoY)	12.56%
Shares held by insiders	6.15%
Shares held by institutions	114.98%
Short ratio	9.1 days

Deeper analysis on BST/BSFA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BST/BSFA report

Is a complete BST/BSFA research report available?

No complete published report is available for bst/BSFA (BST/BSFA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BST/BSFA (BST/BSFA)

Price

Financial snapshot

Fair-value bridge

Latest news · BST/BSFA

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All BST/BSFA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BST/BSFA

Frequently asked questions